Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: The CARMEN study

Chew, 2006, Incidence of venous thromboembolism and its effects on survival among patients with common cancers, Arch Intern Med, 166, 458, 10.1001/archinte.166.4.458

Levitan, 1999, Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data, Medicine, 78, 285, 10.1097/00005792-199909000-00001

Noble, 2010, Epidemiology and pathophysiology of cancer-associated thrombosis, Br J Cancer, 13, S2, 10.1038/sj.bjc.6605599

Sorensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504

Sandhu, 2010, The Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Primary Bladder Cancer, Cancer, 116, 2596, 10.1002/cncr.25004

Meyer, 2002, Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study, Arch Intern Med, 162, 1729, 10.1001/archinte.162.15.1729

Lee, 2003, Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, 349, 146, 10.1056/NEJMoa025313

Hull, 2006, Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer, Am J Med, 119, 1062, 10.1016/j.amjmed.2006.02.022

Akl, 2011, Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer, Cochrane Database Syst Rev, 15

Mandala, 2008, Management of venous thromboembolism in cancer patients: ESMO clinical recommendations, Ann Oncol, 19, 126, 10.1093/annonc/mdn110

Lyman, 2007, American Society of Clinical Oncology Guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer, J Clin Oncol, 25, 5490, 10.1200/JCO.2007.14.1283

Wagman, 2006, Venous thromboembolic disease. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 4, 838, 10.6004/jnccn.2006.0071

Debourdeau, 2009, 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheter in patients with cancer: report from the working group, Ann Oncol, 20, 1459, 10.1093/annonc/mdp052

Farge, 2010, 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group, Crit Rev Oncol Hematol, 73, 31, 10.1016/j.critrevonc.2008.12.004

Lyman, 2013, Venous thromboembolism prophylaxis and treatment in patients with cancer. ASCO practice guidelines update, J Clin Oncol, 31, 2189, 10.1200/JCO.2013.49.1118

Khorana, 2013, Incidence and predictors of venous thromboembolism among ambulatory high-risk patients undergoing chemotherapy in the United States, Cancer, 119, 648, 10.1002/cncr.27772

Delate, 2012, Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer, Oncologist, 17, 419, 10.1634/theoncologist.2011-0323

Spirk, 2011, Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer, Thromb Haemost, 105, 962, 10.1160/TH11-01-0002

Farge, 2013, International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, J Thromb Haemost, 11, 56, 10.1111/jth.12070

Debourdeau, 2013, International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, J Thromb Haemost, 11, 71, 10.1111/jth.12071